null
ChEBI ID: 48009
| Member | Definition | Role |
|---|---|---|
| azacitidine | An N-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1H)-one substituted by a beta-D-ribofuranosyl residue via an N-glycosidic linkage. An antineoplastic agent, it is used in the treatment of myeloid leukaemia. | 5-azacytidine |
| fazarabine | An N-glycosyl-1,3,5-triazine that is 4-amino-1,3,5-triazin-2(1H)-one substituted by a beta-D-arabinofuranosyl residue via an N-glycosidic linkage. A synthetic analogue of cytosine arabinoside and 5-azacytidine that incorporates structural features of both compounds, it shows good activity against a variety of transplanted tumors. | fazarabine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 877 (12.05) | 18.7374 |
| 1990's | 589 (8.09) | 18.2507 |
| 2000's | 1,730 (23.76) | 29.6817 |
| 2010's | 3,296 (45.27) | 24.3611 |
| 2020's | 789 (10.84) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 495 (6.57%) | 5.53% |
| Reviews | 553 (7.34%) | 6.00% |
| Case Studies | 359 (4.77%) | 4.05% |
| Observational | 18 (0.24%) | 0.25% |
| Other | 6,105 (81.08%) | 84.16% |